Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT00684918 · ClinicalTrials.gov registry record · Phase 2
Study of Obatoclax in Previously Untreated Acute Myeloid Leukemia (AML)
A Phase 2 study, sponsored by Gemin X.
- Completed
- Registry status
- Phase 2
- Development phase
- 18
- Enrollment target
NCT00684918 is a Phase 2 study that has completed, run by Gemin X. The registered enrollment target is 18 participants.
The verdict
NCT00684918, a Phase 2 study, has completed, sponsored by Gemin X.
- COMPLETED
- Registry status
- Phase 2
- Development phase
- 18 participants
- Enrollment target
Study Summary
This protocol will evaluate the efficacy of obatoclax in older patients with previously untreated AML.
Interventions
- DRUG Obatoclax
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 18 participants |
| Start Date | 2008-04 |
| Est. Completion | 2009-12 |
| Phase | Phase 2 |
Interested in This Trial?
Full Details on ClinicalTrials.gov ↗What the Registry Record Tells You About NCT00684918
The ClinicalTrials.gov registry entry for NCT00684918 describes a study currently listed as completed, categorized as Phase 2. The registered enrollment target is 18 participants, a figure that helps gauge the scale of data the investigators plan to collect. The listed sponsor is Gemin X, which has 11 total studies on file at ClinicalTrials.gov.
The record links to 0 conditions, and to 1 intervention - of which Obatoclax is the first listed.
NCT00684918 reports 0 study locations.
Frequently Asked Questions
What is clinical trial NCT00684918 about?
NCT00684918 is a clinical study titled "Study of Obatoclax in Previously Untreated Acute Myeloid Leukemia (AML)". This protocol will evaluate the efficacy of obatoclax in older patients with previously untreated AML.
What is the current status of trial NCT00684918?
This trial is currently completed. It is a Phase 2 study. The enrollment target is 18 participants. The study started on 2008-04. Estimated completion is 2009-12.
What interventions are being tested in trial NCT00684918?
The interventions under investigation include: Obatoclax (DRUG).
Who is sponsoring clinical trial NCT00684918?
This trial is sponsored by Gemin X, which has 11 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
Explore more on PlainTrial
Read our methodology - how this data is sourced, computed, and verified.
Related
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.